为“减肥针”用户打造的健身课，成了一门新生意

Core Insights - The rise of GLP-1 weight loss drugs, exemplified by Ozempic, is transforming weight loss into a more direct and rapid process, but it also necessitates a greater focus on fitness due to muscle loss during weight reduction [1][3][5] - The fitness industry is innovating to cater to the growing demographic of GLP-1 users, with gyms developing specialized programs to attract this new customer base [1][10] Group 1: Impact on Health and Fitness - GLP-1 drugs reduce appetite, leading to significant weight loss, but approximately 25% to 33% of this weight loss comes from muscle mass, which poses health risks, especially for older adults and postmenopausal women [3][5] - Users of GLP-1 medications often experience side effects such as nausea and reduced appetite, which can lead to nutritional deficiencies and decreased energy levels, making it challenging to maintain a regular fitness routine [8][9] - Customized fitness programs for GLP-1 users are emerging, focusing on resistance training and nutritional education to help users establish healthier habits [10][12] Group 2: Industry Response and Opportunities - Fitness chains like Equinox are launching GLP-1 protocols to train coaches on the drug's mechanisms and how to tailor fitness plans for users, expanding this training globally [12][14] - Companies are developing products specifically for GLP-1 users, such as Nestlé's Vital Pursuit line, which emphasizes high protein and small portions to meet the new dietary needs of this demographic [18][20] - The market for weight loss drugs is projected to grow significantly, with Morgan Stanley increasing its estimate for the global weight loss drug market to $150 billion by 2035, indicating a substantial opportunity for related industries [26]